Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model

被引:45
作者
Shindo, T [1 ]
Kurihara, H [1 ]
Kurihara, Y [1 ]
Morita, H [1 ]
Yazaki, Y [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan
关键词
endothelin-1; adrenomedullin; endotoxin shock;
D O I
10.1097/00005344-199800001-00156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Septic shock is a life-threatening disorder caused by lipopolysaccharide (LPS) and other bacterial products. Accumulating, evidence indicates a role for vasoactive substances and cytokines in this disease process. In this study we examined the effect of LPS on the gene expression of endothelin-1 (ET-1) and adrenomedullin (AM), two major vasoactive peptides predominantly produced by vascular endothelial cells, to investigate their role in the pathophysiology of septic shock. LPS induced ET-1 and AM gene expression in the heart, lung, kidney, liver, and aorta within 6 h. In the liver, whereas basal ET-1 and AM mRNA were hardly detectable, ET-1 and AM gene expression and peptide production were markedly increased by LPS. This LPS-induced upregulation of ET-1 and AM expression is greatly potentiated by D-galactosamine (D-GalN), although D-GalN alone could not induce ET-1 and AM gene expression. These results, together with the previous findings that liver injury induced by LPS and D-GalN is mainly mediated by tumor necrosis factor-alpha (TNF-alpha), suggest that the LPS-cytokine pathway may cause upregulation of ET-1 and AM production, leading to dysregulation of systemic and regional vascular tone.
引用
收藏
页码:S541 / S544
页数:4
相关论文
共 21 条
[1]   GALACTOSAMINE-INDUCED SENSITIZATION TO THE LETHAL EFFECTS OF ENDOTOXIN [J].
GALANOS, C ;
FREUDENBERG, MA ;
REUTTER, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5939-5943
[2]   MECHANISMS OF ADRENOMEDULLIN-INDUCED VASODILATION IN THE RAT-KIDNEY [J].
HIRATA, Y ;
HAYAKAWA, H ;
SUZUKI, Y ;
SUZUKI, E ;
IKENOUCHI, H ;
KOHMOTO, O ;
KIMURA, K ;
KITAMURA, K ;
ETO, T ;
KANGAWA, K ;
MATSUO, H ;
OMATA, M .
HYPERTENSION, 1995, 25 (04) :790-795
[3]   PLASMA-LEVELS OF ADRENOMEDULLIN, A NEWLY IDENTIFIED HYPOTENSIVE PEPTIDE, IN PATIENTS WITH HYPERTENSION AND RENAL-FAILURE [J].
ISHIMITSU, T ;
NISHIKIMI, T ;
SAITO, Y ;
KITAMURA, K ;
ETO, T ;
KANGAWA, K ;
MATSUO, H ;
OMAE, T ;
MATSUOKA, H .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2158-2161
[4]   Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells [J].
Kano, H ;
Kohno, M ;
Yasunari, K ;
Yokokawa, K ;
Horio, T ;
Ikeda, M ;
Minami, M ;
Hanehira, T ;
Takeda, T ;
Yoshikawa, J .
JOURNAL OF HYPERTENSION, 1996, 14 (02) :209-213
[5]   ADRENOMEDULLIN - A NOVEL HYPOTENSIVE PEPTIDE ISOLATED FROM HUMAN PHEOCHROMOCYTOMA [J].
KITAMURA, K ;
KANGAWA, K ;
KAWAMOTO, M ;
ICHIKI, Y ;
NAKAMURA, S ;
MATSUO, H ;
ETO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :553-560
[6]   Plasma adrenomedullin concentrations in essential hypertension [J].
Kohno, M ;
Hanehira, T ;
Kano, H ;
Horio, T ;
Yokokawa, K ;
Ikeda, M ;
Minami, M ;
Yasunari, K ;
Yoshikawa, J .
HYPERTENSION, 1996, 27 (01) :102-107
[7]   LETHAL TOXICITY OF LIPOPOLYSACCHARIDE AND TUMOR-NECROSIS-FACTOR IN NORMAL AND D-GALACTOSAMINE-TREATED MICE [J].
LEHMANN, V ;
FREUDENBERG, MA ;
GALANOS, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :657-663
[8]   ENDOTHELIUM-DERIVED CONTRACTING FACTORS [J].
LUSCHER, TF ;
BOULANGER, CM ;
DOHI, Y ;
YANG, ZH .
HYPERTENSION, 1992, 19 (02) :117-130
[9]  
MAEMURA K, 1992, GERONTOLOGY, V38, P29
[10]  
MAEMURA K, 1995, J CARDIOVASC PHARM, V26, pS17